Jacob Kaufman
@jkaufmanlungned.bsky.social
Physician Scientist; Thoracic Med Onc; Research focused on STK11 mutant lung cancer. Things I love: my family, my OSU colleagues, awesome patients and pt advocates, sciency geeky things, everything and everyone raising the bar in lung cancer, being weird.
I gotta keep this article on hand to share with colleagues whose grants dont make the payline
Or if I offer them too much consolation is that going to negate the effect? 🤔
Or if I offer them too much consolation is that going to negate the effect? 🤔
November 26, 2024 at 12:10 AM
I gotta keep this article on hand to share with colleagues whose grants dont make the payline
Or if I offer them too much consolation is that going to negate the effect? 🤔
Or if I offer them too much consolation is that going to negate the effect? 🤔
I’d be honored if you’d add me
November 25, 2024 at 6:55 PM
I’d be honored if you’d add me
Reposted by Jacob Kaufman
You’re gonna rock the lecture, Jinesh!
November 25, 2024 at 2:07 AM
You’re gonna rock the lecture, Jinesh!
Will be exciting to see prospective data from Triton in STK11 and KEAP1 patients
I am looking forward beyond that to the prospect of truly precision IO for these resistant populations
I am looking forward beyond that to the prospect of truly precision IO for these resistant populations
November 25, 2024 at 2:06 AM
Will be exciting to see prospective data from Triton in STK11 and KEAP1 patients
I am looking forward beyond that to the prospect of truly precision IO for these resistant populations
I am looking forward beyond that to the prospect of truly precision IO for these resistant populations
Wish I could’ve been there! Say anything exciting about STK11 future directions?
November 25, 2024 at 1:31 AM
Wish I could’ve been there! Say anything exciting about STK11 future directions?